Company intelligence / Profile preview

Brucker

Billerica, Massachusetts, United Statesbruckerco.com ↗

Ownership: Private
Employees: ~8500
Development stage: Commercial

Overview

Bruker's high-value analytical instruments and diagnostic solutions enable scientists to make breakthrough discoveries in life sciences. Their recent acquisitions have expanded their capabilities into single-cell biology, spatial biology, proteomics/multiomics, functional structural biology, clinical microbiology diagnostics, and more. They do not develop therapeutics themselves but provide essential platforms that accelerate drug discovery/development across academia and industry.

Modalities: AntibodyCell therapyGene therapyVaccine
Industry: Protein Biomarker Diagnostics

Partnerships

NovAliX

Beyond the preview

Go deeper on Brucker.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brucker.

Explore the full profile